Imiquimod Cream
Product Images NDC 45802-368

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 45802-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2h162rcc2

Imiquimod Cream 5% is a topical medication used for the treatment of actinic keratosis and superficial basal cell carcinoma. It comes in 24 single-use packets, with a net weight of 0.25g per packet and 6g per carton. It is for dermatologic use only and should not be used for ophthalmic purposes. The provided text appears to include some extra unrelated characters and random symbols.*

FDA Label Image

Image 01

FDA Label Image

Image 02

This is a clinical trial report of Imiquimod Cream, 5% Vehicle Cream for the treatment of external genital warts. There were 209 participants enrolled in the study, and the figure shows subject accountability throughout the trial period. Some participants completed 16 weeks of treatment while others withdrew. Out of the total participants, some cleared of warts and completed 12 weeks of follow-up, while others were lost to follow-up or experienced recurrences.*

FDA Label Image

Image 04

This text is a warning for the use of Imiquimod Cream, specifying that it should only be used topically on the skin and not in or near the mouth, eyes, nose, or vagina.*

FDA Label Image

Serialization Template

This text provides a template for inserting a product's serial number, lot number, and expiration date. It does not provide any additional information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.